Prepandemic influenza vaccine (H5N1) (split virion, inactivated, adjuvanted)(GlaxoSmithKline)

N/A

Report date: 2022/01/14 13:23:58

Base Information

Drug NamePrepandemic influenza vaccine (H5N1) (split virion, inactivated, adjuvanted)(GlaxoSmithKline)
Drug Alias NameH5N1裂解灭活佐剂疫苗（GlaxoSmithKline）大流行流感疫苗（GlaxoSmithKline）PrepandrixGSK-2592984AGSK-1557484A +[7] 
ClassificationVaccines > Biological material > Viral vaccineVaccines > Application > Prophylactic vaccineVaccines > Development/production technology > Inactivated vaccine > Split vaccine
Mechanisms of ActionImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsInfluenza, Human
Global Approved IndicationsInfluenza, Human
Approved Indications in ChinaN/A
Original Approved Country/TerritoryEU
Original Approved Date2008/05/14
Country/TerritoryBelgiumCanadaUnited States +[14] 
CombinationsNo
Global Highest StatusWithdrawn
Highest Status in ChinaN/A
Originator CompaniesGlaxosmithkline Plc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesGlaxosmithkline PlcGlaxosmithkline Biologicals SA
Active IndicationsN/A
Inactive IndicationsInfluenza, Human

Other Information

ATC CodeJ07BB02
Related LinksN/A